Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mazza

Showing results (1-10 of 173) with videos related to

Pageof 18
Sort By:
Bollettino Chimico Farmaceutico|November 1, 1992
[Therapeutic perspectives on antisense oligonucleotides]P Mazza
Bollettino Chimico Farmaceutico|October 1, 1991
[The current state and future prospectives on the therapeutic administration of peptides and proteins of biotechnological origin]P Mazza
Bollettino Chimico Farmaceutico|January 1, 1994
The use of Bacillus subtilis as an antidiarrhoeal microorganismP Mazza
Bollettino Chimico Farmaceutico|March 1, 1991
[Recombinant DNA technology in thrombolytic therapy: tissue-type plasminogen activator]P Mazza
Bollettino Chimico Farmaceutico|September 1, 1993
[Biotechnologic strategy for the study of the pathogenic action of bacteria]P Mazza
Bollettino Chimico Farmaceutico|January 1, 1994
[Cystic fibrosis: molecular aspects and therapeutic prospects]P Mazza
Bollettino Chimico Farmaceutico|July 1, 1993
[Pharmaceutical biotechnology]P Mazza
Bollettino Chimico Farmaceutico|November 1, 1994
[Antibiotic resistance: current problems and prospects]P Mazza
Bollettino Chimico Farmaceutico|May 1, 1991
[Biotechnology and diagnosis: the molecular DNA probe]P Mazza
Microbiologica|April 1, 1989
Revised genetics of DNA metabolism in Bacillus subtilisP Mazza, A Galizzi
Pageof 18

Showing results (1-10 of 173) with videos related to

Sort By:
Pageof 18
Bollettino Chimico Farmaceutico|November 1, 1992
[Therapeutic perspectives on antisense oligonucleotides]P Mazza
Bollettino Chimico Farmaceutico|October 1, 1991
[The current state and future prospectives on the therapeutic administration of peptides and proteins of biotechnological origin]P Mazza
Bollettino Chimico Farmaceutico|January 1, 1994
The use of Bacillus subtilis as an antidiarrhoeal microorganismP Mazza
Bollettino Chimico Farmaceutico|March 1, 1991
[Recombinant DNA technology in thrombolytic therapy: tissue-type plasminogen activator]P Mazza
Bollettino Chimico Farmaceutico|September 1, 1993
[Biotechnologic strategy for the study of the pathogenic action of bacteria]P Mazza
Bollettino Chimico Farmaceutico|January 1, 1994
[Cystic fibrosis: molecular aspects and therapeutic prospects]P Mazza
Bollettino Chimico Farmaceutico|July 1, 1993
[Pharmaceutical biotechnology]P Mazza
Bollettino Chimico Farmaceutico|November 1, 1994
[Antibiotic resistance: current problems and prospects]P Mazza
Bollettino Chimico Farmaceutico|May 1, 1991
[Biotechnology and diagnosis: the molecular DNA probe]P Mazza
Microbiologica|April 1, 1989
Revised genetics of DNA metabolism in Bacillus subtilisP Mazza, A Galizzi
Pageof 18